Blue Cross Blue Shield - South Dakota Prior Authorization Lookup
- Blue Cross Blue Shield - South Dakota coverage criteria
- All Blue Cross Blue Shield - South Dakota policy updates
Latest Blue Cross Blue Shield - South Dakota prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-10-18Xiaflex (collagenase clostridium histolyticum) Coverage and Prior AuthorizationThis policy governs coverage and prior authorization requirements for Xiaflex for adults with Dupuytren's contracture or Peyronie's disease. Coverage requires applicable clinical, documentation, provider, and dosing criteria, and benefits remain subject to the member's contract.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-30Bylvay (odevixibat) Coverage CriteriaThis policy governs prior authorization coverage for Bylvay (odevixibat) to treat pruritus associated with progressive familial intrahepatic cholestasis (PFIC) or cholestatic pruritus associated with Alagille syndrome (ALGS), subject to clinical criteria, documentation, specialist involvement, exclusions, and dosing limits.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-21Lumvoa (veligrotug-vvze) and Tepezza (teprotumumab-trbw)This policy governs medical necessity and prior authorization for Lumvoa (veligrotug-vvze) and Tepezza (teprotumumab-trbw) in members with thyroid eye disease. Coverage requires the applicable clinical criteria, documentation, specialist involvement, and benefit eligibility.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-20Tavneos (avacopan) Coverage PolicyThis policy governs coverage and prior authorization for Tavneos (avacopan) as adjunctive treatment for adults with severe active ANCA-associated vasculitis, specifically granulomatosis with polyangiitis or microscopic polyangiitis. Coverage requires documented clinical criteria, specialist prescribing or consultation for initial requests, and applicable benefit eligibility.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-06Glucosylceramide Synthase Inhibitors for Gaucher Disease and Niemann-Pick Disease (Elelyso, Cerdelga, Cerezyme, VPRIV, and miglustat/Yargesa/Zavesca)This policy governs coverage, prior authorization, preferred-product requirements, medical-necessity criteria, continuation criteria, and dosing or quantity limits for therapies used to treat type 1 or type 3 Gaucher disease and Niemann-Pick disease type C.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-15Yartemlea (narsoplimab-wuug) Coverage for Transplant-Associated Thrombotic MicroangiopathyThis policy governs prior authorization and medical-necessity criteria for Yartemlea (narsoplimab-wuug) used to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). It applies to members whose benefits include the therapy and who meet the initial or continuation criteria.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-19Fabhalta (iptacopan) Coverage CriteriaCoverage of Fabhalta for adults with paroxysmal nocturnal hemoglobinuria, primary immunoglobulin A nephropathy, or complement 3 glomerulopathy, subject to indication-specific clinical criteria, documentation, prescriber specialty requirements, and prior authorization.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-17Rezdiffra (resmetirom) CoveragePrior authorization and coverage criteria for Rezdiffra (resmetirom) in adults with noncirrhotic MASH and moderate to advanced F2-F3 liver fibrosis.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-10Tarpeyo (budesonide delayed release) capsulesThis policy governs prior authorization and coverage of Tarpeyo capsules for members with primary immunoglobulin A nephropathy who are at risk for disease progression.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Empaveli (pegcetacoplan) Coverage and Prior AuthorizationCoverage and prior authorization requirements for Empaveli in adults with paroxysmal nocturnal hemoglobinuria (PNH) and adults or patients aged 12 years and older with complement 3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN).All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Mulpleta (lusutrombopag) Coverage PolicyThis policy governs prior authorization and coverage of Mulpleta for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a procedure. Coverage requires applicable preferred-drug and clinical criteria and is subject to exclusions, documentation, and quantity limits.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Tavalisse Coverage for Chronic Immune ThrombocytopeniaThis policy governs prior authorization and coverage of Tavalisse (fostamatinib disodium hexahydrate) for eligible adults with chronic immune thrombocytopenia, subject to plan design, clinical criteria, documentation, and applicable exclusions.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Voydeya (danicopan) coverage for paroxysmal nocturnal hemoglobinuriaThis policy governs prior authorization and medical necessity requirements for Voydeya (danicopan) used as add-on therapy to ravulizumab or eculizumab for extravascular hemolysis in adults with paroxysmal nocturnal hemoglobinuria. Coverage applies when the documented clinical, laboratory, prescriber, concomitant-therapy, and dosing requirements are met.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Zilbrysq (zilucoplan) Coverage for Generalized Myasthenia GravisThis policy governs prior authorization and coverage of Zilbrysq (zilucoplan) for adult members with acetylcholine receptor antibody-positive generalized myasthenia gravis. Coverage requires the applicable clinical criteria, documentation, dosing limits, and continuation requirements to be met.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-20Xolremdi (mavorixafor) Coverage for WHIM SyndromePrior authorization and medical-necessity criteria for Xolremdi in members age 12 years and older with WHIM syndrome.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-19Jesduvroq (daprodustat) CoveragePrior authorization coverage for Jesduvroq to treat anemia due to chronic kidney disease in adults receiving dialysis, subject to clinical, safety, prescriber, documentation, and dosing criteria.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-19Lyfgenia (lovotibeglogene autotemcel) Coverage for Sickle Cell DiseasePrior authorization and medical necessity review for Lyfgenia in members with sickle cell disease; coverage requires specified clinical, laboratory, genetic, documentation, and prescriber requirements and is limited to one treatment course per lifetime.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-19Vafseo (vadadustat) CoverageThis policy governs prior authorization coverage of Vafseo for adults with anemia due to chronic kidney disease who have received dialysis for at least three months. Coverage requires fulfillment of the applicable initial or continuation criteria, documentation, prescriber qualifications, and dosing limits.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-18Ocaliva (obeticholic acid) Coverage CriteriaPrior authorization coverage for Ocaliva in adults with primary biliary cholangitis, requiring documented clinical criteria, specialist prescribing or consultation, required laboratory information, and no specified cirrhosis-related exclusions.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-08-30Qfitlia® (fitusiran) Coverage for Hemophilia ProphylaxisPrior authorization and coverage of Qfitlia for routine prophylaxis in adults and pediatric members age 12 and older with hemophilia A or B, subject to clinical criteria, documentation requirements, prescriber qualifications, monitoring, and quantity limits.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-05-30Ultomiris (ravulizumab) Coverage CriteriaThis policy governs prior authorization and medical-necessity coverage for Ultomiris (ravulizumab) used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disorder. Coverage requires applicable diagnosis-specific criteria, documentation, and absence of therapy exclusions.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-04-09Oxervate (cenegermin-bkbj) Coverage CriteriaCoverage and prior authorization for Oxervate for members with Stage 2 or Stage 3 neurotrophic keratitis, subject to clinical criteria, specialist involvement, and applicable benefit exclusions.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2025-01-01Intravenous IronCoverage and prior authorization for specified intravenous iron products, including preferred products and non-preferred products subject to a clinical exception process.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2024-01-01Roctavian (valoctocogene roxaparvovec-rvox) Coverage CriteriaThis policy governs prior authorization and medical-necessity coverage for Roctavian in adults with severe congenital hemophilia A. Coverage requires clinical, laboratory, prescriber, liver-health, and treatment-history criteria and is limited to one treatment per lifetime.All blue cross blue shield - south dakota updates
- Prior AuthClinical/Medical PolicyEff. 2023-07-17Vowst (fecal microbiota spores, live-brpk) Coverage and Prior AuthorizationCoverage and prior authorization for Vowst used to prevent recurrence of Clostridioides difficile infection in eligible adults, subject to approval criteria, exclusions, limitations, and benefit verification.All blue cross blue shield - south dakota updates
Tool Description
Search Blue Cross Blue Shield - South Dakotaprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.